• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗佐剂的发展趋势:DAMPs 和 PAMPs 作为潜在的新型佐剂。

Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.

机构信息

Centro de Biotecnologia, Instituto Butantan, Av. Vital Brasil 1500, São Paulo, SP, Brazil.

出版信息

Braz J Med Biol Res. 2011 Jun;44(6):500-13. doi: 10.1590/s0100-879x2011007500064. Epub 2011 May 13.

DOI:10.1590/s0100-879x2011007500064
PMID:21584443
Abstract

Aluminum salts have been widely used in vaccine formulations and, after their introduction more than 80 years ago, only few vaccine formulations using new adjuvants were developed in the last two decades. Recent advances in the understanding of how innate mechanisms influence the adaptive immunity opened up the possibility for the development of new adjuvants in a more rational design. The purpose of this review is to discuss the recent advances in this field regarding the attempts to determine the molecular basis and the general mechanisms underlying the development of new adjuvants, with particular emphasis on the activation of receptors of innate immune recognition. One can anticipate that the use of these novel adjuvants will also provide a window of opportunities for the development of new vaccines.

摘要

铝盐已被广泛应用于疫苗制剂中,自 80 多年前引入以来,在过去的二十年中,仅开发了少数使用新型佐剂的疫苗制剂。最近对先天机制如何影响适应性免疫的理解的进展为新佐剂的开发提供了更合理的设计的可能性。本文的目的是讨论该领域的最新进展,尝试确定新佐剂开发的分子基础和一般机制,特别强调先天免疫识别受体的激活。人们可以预期,这些新型佐剂的使用也将为新疫苗的开发提供机会。

相似文献

1
Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.疫苗佐剂的发展趋势:DAMPs 和 PAMPs 作为潜在的新型佐剂。
Braz J Med Biol Res. 2011 Jun;44(6):500-13. doi: 10.1590/s0100-879x2011007500064. Epub 2011 May 13.
2
Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.释放NOD样和Toll样激动剂作为疫苗佐剂的潜力。
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12294-9. doi: 10.1073/pnas.1400478111. Epub 2014 Aug 18.
3
Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.模式识别受体:先天免疫中的哨兵和新型疫苗佐剂的靶标。
Expert Rev Vaccines. 2012 Feb;11(2):237-56. doi: 10.1586/erv.11.189.
4
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.探索模式识别受体激动剂作为候选佐剂。
Front Cell Infect Microbiol. 2021 Oct 6;11:745016. doi: 10.3389/fcimb.2021.745016. eCollection 2021.
5
Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.靶向模式识别受体 (PRR) 用于疫苗佐剂:从合成 PRR 激动剂到病毒缺陷干扰颗粒的潜力。
Viruses. 2017 Jul 13;9(7):186. doi: 10.3390/v9070186.
6
Strategies to link innate and adaptive immunity when designing vaccine adjuvants.设计疫苗佐剂时连接固有免疫和适应性免疫的策略。
Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):184-91. doi: 10.1016/j.vetimm.2008.10.298. Epub 2008 Oct 17.
7
Immunological Mechanism and Clinical Application of PAMP Adjuvants.免疫佐剂的免疫机制及其临床应用
Recent Pat Anticancer Drug Discov. 2021;16(1):30-43. doi: 10.2174/1574892816666210201114712.
8
Flagellin as a vaccine adjuvant.鞭毛蛋白作为疫苗佐剂。
Expert Rev Vaccines. 2018 Apr;17(4):335-349. doi: 10.1080/14760584.2018.1457443. Epub 2018 Mar 30.
9
Smart adjuvants.智能佐剂
Expert Rev Vaccines. 2007 Jun;6(3):391-400. doi: 10.1586/14760584.6.3.391.
10
Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.基于训练免疫的疫苗:广谱抗感染配方开发的新模式。
Front Immunol. 2018 Dec 17;9:2936. doi: 10.3389/fimmu.2018.02936. eCollection 2018.

引用本文的文献

1
Modified dipeptide based nanospheres as a potent adjuvating delivery system for recombinant vaccines.基于修饰二肽的纳米球作为重组疫苗的高效佐剂递送系统。
Front Drug Deliv. 2023 Apr 26;3:1135209. doi: 10.3389/fddev.2023.1135209. eCollection 2023.
2
Calboxyvinyl polymer adjuvant enhances respiratory iga responses through mucosal and systemic administration.羧乙烯基聚合物佐剂通过黏膜和全身给药增强呼吸道IgA反应。
NPJ Vaccines. 2025 Feb 11;10(1):28. doi: 10.1038/s41541-025-01086-0.
3
Alcaligenes lipid A functions as a superior mucosal adjuvant to monophosphoryl lipid A via the recruitment and activation of CD11b+ dendritic cells in nasal tissue.
在鼻组织中,Algencs 脂 A 通过募集和激活 CD11b+树突状细胞,起到比单磷酰脂质 A 更优越的黏膜佐剂作用。
Int Immunol. 2024 Jan 29;36(1):33-43. doi: 10.1093/intimm/dxad045.
4
Immunological Effects of Dimethyldioctadecylammonium Bromide and Saponin as Adjuvants for Outer Membrane Vesicles from .溴化二甲基二十八烷基铵和皂苷作为[具体来源]外膜囊泡佐剂的免疫学效应
Diseases. 2022 Jul 19;10(3):46. doi: 10.3390/diseases10030046.
5
Peptide vaccines designed with the aid of immunoinformatic against Caseous Lymphadenitis promotes humoral and cellular response induction in mice.利用免疫信息学设计针对干酪样淋巴结炎的肽疫苗可诱导小鼠产生体液和细胞应答。
PLoS One. 2021 Nov 29;16(11):e0256864. doi: 10.1371/journal.pone.0256864. eCollection 2021.
6
Production and Immunogenicity of a Tag-Free Recombinant Chimera Based on PfMSP-1 and PfMSP-3 Using Alhydrogel and Dipeptide-Based Hydrogels.基于PfMSP-1和PfMSP-3,使用氢氧化铝凝胶和二肽基水凝胶制备无标签重组嵌合体及其免疫原性
Vaccines (Basel). 2021 Jul 13;9(7):782. doi: 10.3390/vaccines9070782.
7
Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their Adjuvant Activity.结构精细调整脱酰基肽 NOD2 激动剂定义了它们的佐剂活性。
J Med Chem. 2021 Jun 10;64(11):7809-7838. doi: 10.1021/acs.jmedchem.1c00644. Epub 2021 May 27.
8
Outer Membrane Vesicles of 7.13 as Adjuvants Promote Protective Efficacy Against Infection.7.13的外膜囊泡作为佐剂可提高抗感染的保护效力。
Front Microbiol. 2020 Jun 23;11:1340. doi: 10.3389/fmicb.2020.01340. eCollection 2020.
9
Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against Infection.包含修饰型细菌超抗原和 Cruzipain 结构域的异源嵌合构建体赋予对 感染的保护作用。
Front Immunol. 2020 Jun 30;11:1279. doi: 10.3389/fimmu.2020.01279. eCollection 2020.
10
Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.靶向自然杀伤细胞以增强免疫和控制适应性免疫反应。
Front Cell Infect Microbiol. 2020 May 19;10:231. doi: 10.3389/fcimb.2020.00231. eCollection 2020.